Patents by Inventor Richard Hill

Richard Hill has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20190008635
    Abstract: The present technology is a prosthetic heart valve device, and related systems and methods, for treating a native valve of a human heart having a native annulus and native leaflets. One embodiment comprises a valve support, a prosthetic valve assembly within the valve support, and an anchoring member having an upstream portion and a downstream portion. The device further includes an extension member coupled to the fixation frame and extending radially outward therefrom. The extension member includes a plurality of wires, at least a portion of which include an inner core surrounded by an outer material. The wires include a plurality of recesses extending through at least a portion of the thickness of the outer material, and a therapeutic agent in the recesses for delivery to the anatomy when the prosthetic heart valve device is positioned at a native annulus.
    Type: Application
    Filed: July 6, 2017
    Publication date: January 10, 2019
    Inventors: Richard Francis, Scott Robertson, Marian Lally, Alexander Hill, Katherine Miyashiro, Paraic Frisby, James R. Keogh
  • Publication number: 20190008657
    Abstract: An expandable fusion cage system includes an expandable fusion cage having an upper portion, a lower portion, and a hinge portion coupling the lower portion and the upper portion at their distal ends. Positioned between the upper and lower portions is an expansion element that when moved in the proximal direction causes the cage to expand at its proximal end. The system can also include inserter instruments, expandable distraction instruments, and bone funnels.
    Type: Application
    Filed: August 6, 2018
    Publication date: January 10, 2019
    Applicant: IN QUEUE INNOVATIONS, LLC
    Inventors: Andrew LAMBORNE, Patrick HUNT, Joel HELGERSON, Troy WOOLLEY, Richard FESSLER, Clint HILL, K. Brandon STRENGE, Kenneth LITTLE, Alex SPECIALE
  • Publication number: 20180325732
    Abstract: Devices and methods for treating intraocular pressure are disclosed. The devices include shunts for draining aqueous humor from the anterior chamber to the uveoscleral outflow pathway, including the supraciliary space and the suprachoroidal space. The shunts are preferably implanted by ab interno procedures.
    Type: Application
    Filed: May 4, 2018
    Publication date: November 15, 2018
    Inventors: Thomas W. Burns, David Haffner, Harold A. Heitzmann, Todd N. Fjield, Richard A. Hill
  • Publication number: 20180225887
    Abstract: A pipette check station for checking the calibration or service status of a pipette includes an RFID reader, a user interface with a display and buttons, and a digital interface to connect the check station to additional equipment; the check station optionally further includes provisions to hold pipettes for storage and to charge electronic pipettes held thereupon.
    Type: Application
    Filed: January 1, 2018
    Publication date: August 9, 2018
    Applicant: Mettler-Toledo Rainin, LLC
    Inventors: Gerhard Keller, Richard Hill, Deryl Stanley, James Petrek, Murray Anderson
  • Publication number: 20180161205
    Abstract: Implants and methods for treating ocular disorders are provided. One method involves introducing an implant into an anterior chamber of an eye. The implant is implanted into eye tissue adjacent the anterior chamber such that a proximal end of the implant resides in the anterior chamber following implantation. A therapeutic agent is eluted from the implant into the eye. Desirably, the release of the therapeutic agent from the implant is controlled. The controlled release of the therapeutic agent can be at a chosen rate and/or for a selected duration which can be episodic or periodic. The therapeutic agent can be an antiproliferative agent, an anti-inflammatory drug, or a compound for treating glaucoma or ocular hypertension.
    Type: Application
    Filed: October 16, 2017
    Publication date: June 14, 2018
    Inventors: Hosheng Tu, Barbara A. Niksch, David S. Haffner, Gregory T. Smedley, Olav B. Bergheim, Morteza Gharib, Richard A. Hill, Thomas W. Burns
  • Patent number: 9993368
    Abstract: Surgical methods and related medical devices for treating ocular disorders are disclosed. Some methods relate to delivering an implant within an eye, and involve providing an elongate guide device, such as, a flexible guide member or a guide wire. A distal end of the guide device can be advanced into an anterior chamber of an eye, or through at least a portion of a site of resistance along a physiologic outflow pathway of the eye, or from an anterior chamber of the eye to a location proximate a physiologic outflow pathway of the eye. The implant is advanced along the guide device toward the guide device distal end, and is positioned to conduct aqueous humor between the anterior chamber and the physiologic outflow pathway.
    Type: Grant
    Filed: October 28, 2010
    Date of Patent: June 12, 2018
    Assignee: Glaukos Corporation
    Inventors: Olav B. Bergheim, Morteza Gharib, Richard A. Hill
  • Patent number: 9987472
    Abstract: Systems and methods for treating ocular disorders are disclosed. One system has a delivery instrument, with a non-linear axis, configured to be inserted into an anterior chamber of an eye and moved to a location proximate a physiologic outflow pathway of the eye. The delivery instrument carries an implant that has a distal end sized for insertion into tissue such that aqueous humor drains from the anterior chamber to the physiologic outflow pathway. One method involves inserting a non-linear portion of a delivery device into the anterior chamber to position an implant within the eye. Another method involves using a delivery device with a curved distal portion to implant an implant at a location communicating with the physiologic outflow pathway. The delivery can be through a corneal incision and the implant can comprise a drug.
    Type: Grant
    Filed: December 27, 2010
    Date of Patent: June 5, 2018
    Assignee: GLAUKOS CORPORATION
    Inventors: Hosheng Tu, Gregory T. Smedley, David Steven Haffner, Barbara A. Niksch, Richard A. Hill, Olav B. Bergheim
  • Patent number: 9962290
    Abstract: Devices and methods for treating intraocular pressure are disclosed. The devices include shunts for draining aqueous humor from the anterior chamber to the uveoscleral outflow pathway, including the supraciliary space and the suprachoroidal space. The shunts are preferably implanted by ab interno procedures.
    Type: Grant
    Filed: August 12, 2013
    Date of Patent: May 8, 2018
    Assignee: Glaukos Corporation
    Inventors: Thomas W. Burns, David Haffner, Harold A. Heitzmann, Todd N. Fjield, Richard A. Hill
  • Publication number: 20180117078
    Abstract: Compositions and methods are provided for enhancing the expression of human beta defensin 2 (HBD2) in human colon epithelium cells. The method comprises orally administering a composition comprising hyaluronan, where said hyaluronan has a molecular weight within the range of about 35 kDa.
    Type: Application
    Filed: October 31, 2017
    Publication date: May 3, 2018
    Inventors: Carol de la MOTTE, Sean KESSLER, David Richard HILL
  • Patent number: 9888265
    Abstract: There is provided a content automation system and a method for use by the content automation system for issuing a content management message for use in a program stream. In one implementation, such a content automation system comprises a processor and a memory, and a stream messaging module residing in the memory. The stream messaging module is configured to issue the content management message by embedding a command sequence as metadata in a container data structure, and inserting the container data structure into the program stream. The command sequence authorizes a replacement of program stream content.
    Type: Grant
    Filed: June 19, 2012
    Date of Patent: February 6, 2018
    Assignee: Disney Enterprises, Inc.
    Inventors: Michael Martin, Daniel Siewers, William Hooper, David Potter, Richard Hill, Michael Strein, Kenneth Michel, Alfredo Vincenty, James Casabella, David Converse, Guy Beverlin
  • Publication number: 20180027263
    Abstract: There is provided a content automation system and a method for use by the content automation system for issuing a content management message for use in a program stream. In one implementation, such a content automation system comprises a processor and a memory, and a stream messaging module residing in the memory. The stream messaging module is configured to issue the content management message by embedding a command sequence as metadata in a container data structure, and inserting the container data structure into the program stream. The command sequence authorizes a replacement of program stream content.
    Type: Application
    Filed: October 3, 2017
    Publication date: January 25, 2018
    Inventors: Michael Martin, Daniel Siewers, William Hooper, David Potter, Richard Hill, Michael Strein, Kenneth Michel, Alfredo Vincenty, James Casabella, David Converse, Guy Beverlin
  • Patent number: 9858729
    Abstract: A pipette check station for checking the calibration or service status of a pipette includes an RFID reader, a user interface with a display and buttons, and a digital interface to connect the check station to additional equipment; the check station optionally further includes provisions to hold pipettes for storage and to charge electronic pipettes held thereupon.
    Type: Grant
    Filed: December 31, 2015
    Date of Patent: January 2, 2018
    Assignee: Mettler-Toledo Rainin, LLC
    Inventors: Gerhard Keller, Richard Hill, Deryl Stanley, James Petrek, Murray Anderson
  • Publication number: 20170368024
    Abstract: Compositions and methods for treating glaucoma by restoring the filtration capabilities of the endothelial lining of Schlemm's canal are provided. More particularly, methods of lowering intraocular pressure are disclosed, where a subject in need of such treatment is administered a therapeutically effective amount of a composition. In various embodiments, the composition may include tyrosine or L-DOPA conjugated to an ascorbic acid, an enzyme, a nucleic acid encoding an enzyme, or trabecular meshwork cells.
    Type: Application
    Filed: December 28, 2015
    Publication date: December 28, 2017
    Inventor: Richard A. Hill
  • Patent number: 9789001
    Abstract: Implants and methods for treating ocular disorders are provided. One method involves introducing an implant into an anterior chamber of an eye. The implant is implanted into eye tissue adjacent the anterior chamber such that a proximal end of the implant resides in the anterior chamber following implantation. A therapeutic agent is eluted from the implant into the eye. Desirably, the release of the therapeutic agent from the implant is controlled. The controlled release of the therapeutic agent can be at a chosen rate and/or for a selected duration which can be episodic or periodic. The therapeutic agent can be an antiproliferative agent, an anti-inflammatory drug, or a compound for treating glaucoma or ocular hypertension.
    Type: Grant
    Filed: June 29, 2015
    Date of Patent: October 17, 2017
    Assignee: DOSE MEDICAL CORPORATION
    Inventors: Hosheng Tu, Barbara A. Niksch, David S. Haffner, Gregory T. Smedley, Olav B. Bergheim, Morteza Gharib, Richard A. Hill, Thomas W. Burns
  • Publication number: 20170246034
    Abstract: Drainage of body fluid from an area of undesirably high pressure can be accomplished by interconnecting an artificial non-blood fluid conduit with the vascular system. For example, an artificial non-blood fluid conduit can be inserted into the eye to fluidly interconnect the anterior chamber with a location of lower pressure. The conduit can have a growth factor for stimulating growth of new blood vessels in the location of lower pressure to connect the new blood vessels with the non-blood fluid conduit.
    Type: Application
    Filed: April 21, 2017
    Publication date: August 31, 2017
    Inventor: Richard A. HILL
  • Patent number: 9700724
    Abstract: An apparatus and method for electrical charge balancing when generating a stimulus during functional neural stimulation is presented. A stimulus pulse is generated (cathodic or anodic), and after a selected delay a charge compensating pulse is generated of an opposite polarity. The electrode circuit discontinuously examines electrode voltage after termination of the stimulus pulse, and utilizes this voltage to determine how long to extend the width of the charge compensating pulse. The electrode circuit thus performs accurate electrical charge cancellation to remove residual charges from the electrode by precisely controlling pulse width for an opposing polarity compensating pulse that need not have the same current level as the stimulus pulse.
    Type: Grant
    Filed: August 23, 2015
    Date of Patent: July 11, 2017
    Assignee: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    Inventors: Wentai Liu, Richard Hill, Yi-Kai Lo, Kuanfu Chen
  • Publication number: 20170193712
    Abstract: A pipette check station for checking the calibration or service status of a pipette includes an RFID reader, a user interface with a display and buttons, and a digital interface to connect the check station to additional equipment; the check station optionally further includes provisions to hold pipettes for storage and to charge electronic pipettes held thereupon.
    Type: Application
    Filed: December 31, 2015
    Publication date: July 6, 2017
    Inventors: Gerhard Keller, Richard Hill, Deryl Stanley, James Petrek, Murray Anderson
  • Patent number: 9655780
    Abstract: Drainage of body fluid from an area of undesirably high pressure can be accomplished by interconnecting an artificial non-blood fluid conduit with the vascular system. For example, an artificial non-blood fluid conduit can be inserted into the eye to fluidly interconnect the anterior chamber with a location of lower pressure. The conduit can have a growth factor for stimulating growth of new blood vessels in the location of lower pressure to connect the new blood vessels with the non-blood fluid conduit.
    Type: Grant
    Filed: September 8, 2015
    Date of Patent: May 23, 2017
    Assignee: Orange County Glaucoma, PC
    Inventor: Richard A. Hill
  • Publication number: 20170049967
    Abstract: Devices, systems and methods for needle free injection include a multi-use needle-free injection device comprising reversibly connected proximate and distal sections, wherein the proximate section comprises a power supply, actuator, circuitry and a housing, and the distal section comprises a disposable nozzle tip prefilled with an injectate, a chemical energetic device, and a dual seal piston barrier between the energetic device and the injectate, wherein the proximate and distal sections and their components are operably linked and configured for single-hand injecting of the injectate.
    Type: Application
    Filed: November 4, 2016
    Publication date: February 23, 2017
    Inventors: David Fouche, Michael Vestel, John P. Marlow, Mark A. Petrie, Robert A. Brown, Hilary Lackritz, Richard A. Hill, Donald English, Mark Nansen, Mark Hansen, Martin Martoza
  • Patent number: D782055
    Type: Grant
    Filed: December 2, 2014
    Date of Patent: March 21, 2017
    Inventor: Martin Richard Hill